Molecular forms of cholecystokinin in plasma from normal and gastrectomized human subjects following a fat meal
- PMID: 3432129
- DOI: 10.1016/0196-9781(87)90062-3
Molecular forms of cholecystokinin in plasma from normal and gastrectomized human subjects following a fat meal
Abstract
The present study was undertaken to characterize molecular forms of cholecystokinin (CCK) in human fat-stimulated plasma by Sephadex G50 column chromatography followed by radioimmunoassays employing 3 different region-specific antibodies. CCK was extracted and concentrated from plasma of healthy subjects by adsorption to SEP-PAK C18 cartridges and from plasma of gastrectomized patients by addition of 96% ethanol. Antibody 1703 binds to carboxy-terminal CCK-peptides containing at least 14 amino acid residues, antibody T204 to sulfated carboxy-terminal CCK-peptides and antibody 5135 to carboxy-terminal forms of CCK and gastrin. Four molecular forms of CCK were consistently demonstrated; peak I eluted in the void volume and comprised 1.8-10.2% of CCK-immunoreactivity, peak II eluted between the void volume and the CCK-33/39 standard and comprised 9.8-21.6%, peak III eluted at the position of the CCK-33/39 standard and comprised 42.4-55.4%, and peak IV eluted between the CCK-33/39 and CCK-14 standards and comprised 25.4-40.1% of CCK immunoreactivity. Since these 4 molecular forms reacted to all 3 CCK-antibodies it is likely that they contain the sulfated tyrosyl and carboxy-terminal regions of CCK and, therefore, possess biological activity.
Similar articles
-
Molecular forms of cholecystokinin in human plasma during infusion of bombesin.Life Sci. 1983 Nov 28;33(22):2197-205. doi: 10.1016/0024-3205(83)90291-6. Life Sci. 1983. PMID: 6645797
-
Plasma cholecystokinin response to oral fat in patients with Billroth I and Billroth II gastrectomy.Ann Surg. 1984 Mar;199(3):276-80. doi: 10.1097/00000658-198403000-00005. Ann Surg. 1984. PMID: 6703789 Free PMC article.
-
Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma.Regul Pept. 1984 Oct;9(3):173-85. doi: 10.1016/0167-0115(84)90070-3. Regul Pept. 1984. PMID: 6098939
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
Plasma cholecystokinin and its precursors in hepatic cirrhosis.J Hepatol. 1997 Aug;27(2):299-305. doi: 10.1016/s0168-8278(97)80175-4. J Hepatol. 1997. PMID: 9288604 Review.
Cited by
-
Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.Br J Clin Pharmacol. 1990 Jun;29(6):770-3. doi: 10.1111/j.1365-2125.1990.tb03701.x. Br J Clin Pharmacol. 1990. PMID: 2378793 Free PMC article. Clinical Trial.
-
Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.Gut. 2003 Jan;52(1):109-15. doi: 10.1136/gut.52.1.109. Gut. 2003. PMID: 12477770 Free PMC article. Clinical Trial.
-
Comparison of ileoanal pouch and rectal function measured by barostat.Dig Dis Sci. 2001 Apr;46(4):731-8. doi: 10.1023/a:1010731813255. Dig Dis Sci. 2001. PMID: 11330405
-
Effects of medium-chain and long-chain triglycerides on antroduodenal motility and small bowel transit time in man.Dig Dis Sci. 1997 Sep;42(9):1933-9. doi: 10.1023/a:1018823512901. Dig Dis Sci. 1997. PMID: 9331158
-
Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans.Gut. 1993 Aug;34(8):1128-32. doi: 10.1136/gut.34.8.1128. Gut. 1993. PMID: 8174967 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical